Pulmonary hypertension: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (Started treatment section) |
imported>Robert Badgett (→Treatment: started 'Perioperative care') |
||
| Line 11: | Line 11: | ||
* [[Prostaglandin]]s, such as [[iloprost]], [[treprostinil]], or [[epoprostenol]]. | * [[Prostaglandin]]s, such as [[iloprost]], [[treprostinil]], or [[epoprostenol]]. | ||
* [[Endothelin]] receptor antagonists such as [[bosentan]]. | * [[Endothelin]] receptor antagonists such as [[bosentan]]. | ||
===Perioperative care=== | |||
The [[preoperative care]] and [[perioperative care]] (including [[intraoperative care]] and [[postoperative care]]) has been reviewed.<ref name="pmid19558745">{{cite journal| author=Hill NS, Roberts KR, Preston IR| title=Postoperative pulmonary hypertension: etiology and treatment of a dangerous complication. | journal=Respir Care | year= 2009 | volume= 54 | issue= 7 | pages= 958-68 | pmid=19558745 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&retmode=ref&cmd=prlinks&id=19558745 }} </ref><ref name="pmid17576968">{{cite journal| author=Lai HC, Lai HC, Wang KY, Lee WL, Ting CT, Liu TJ| title=Severe pulmonary hypertension complicates postoperative outcome of non-cardiac surgery. | journal=Br J Anaesth | year= 2007 | volume= 99 | issue= 2 | pages= 184-90 | pmid=17576968 | |||
| url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&retmode=ref&cmd=prlinks&id=17576968 | doi=10.1093/bja/aem126 }} </ref> | |||
==References== | ==References== | ||
<references/> | <references/> | ||
Revision as of 10:36, 11 June 2010
In medicine, pulmonary hypertension is "increased vascular resistance in the pulmonary circulation, usually secondary to heart diseases or lung diseases."[1]
Diagnosis
The echocardiogram may be more than 10 mm/Hg in error in half of cases.[2]
Treatment
For all patients, consider:
- Inhibitors of phosphodiesterase type 5 (PDE-5), such as sildenafil.
For patients with New York Heart Association (NYHA) class IV symptoms inspite of calcium-channel antagonists, consider:
- Prostaglandins, such as iloprost, treprostinil, or epoprostenol.
- Endothelin receptor antagonists such as bosentan.
Perioperative care
The preoperative care and perioperative care (including intraoperative care and postoperative care) has been reviewed.[3][4]
References
- ↑ Anonymous (2024), Pulmonary hypertension (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Fisher MR, Forfia PR, Chamera E, et al (April 2009). "Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension". Am. J. Respir. Crit. Care Med. 179 (7): 615–21. DOI:10.1164/rccm.200811-1691OC. PMID 19164700. Research Blogging.
- ↑ Hill NS, Roberts KR, Preston IR (2009). "Postoperative pulmonary hypertension: etiology and treatment of a dangerous complication.". Respir Care 54 (7): 958-68. PMID 19558745.
- ↑ Lai HC, Lai HC, Wang KY, Lee WL, Ting CT, Liu TJ (2007). "Severe pulmonary hypertension complicates postoperative outcome of non-cardiac surgery.". Br J Anaesth 99 (2): 184-90. DOI:10.1093/bja/aem126. PMID 17576968. Research Blogging.